| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.31 | 1e-10 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.29 | 4e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |